scholarly article | Q13442814 |
P356 | DOI | 10.1159/000326838 |
P8608 | Fatcat ID | release_sg2b7oapmndkndmvey3chyipy4 |
P698 | PubMed publication ID | 21454964 |
P50 | author | Hae Sang Lee | Q44272108 |
P2093 | author name string | Jin Soon Hwang | |
P2860 | cites work | Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function | Q28590018 |
Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass | Q30442971 | ||
Alternatives to growth hormone stimulation testing in children | Q30957612 | ||
The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. | Q36971944 | ||
Effect of body mass index on peak growth hormone response to provocative testing in children with short stature | Q37482808 | ||
Growth Hormone Testing for the Diagnosis of Growth Hormone Deficiency in Childhood: A Population Register-Based Study | Q38504373 | ||
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations | Q39105413 | ||
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects | Q41678238 | ||
Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary | Q42504254 | ||
Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome | Q42525673 | ||
A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index | Q43272847 | ||
Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency | Q43990425 | ||
Acipimox enhances spontaneous growth hormone secretion in obese women | Q44689975 | ||
Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. | Q44947096 | ||
Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency | Q44968786 | ||
Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests | Q45197394 | ||
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index | Q46630258 | ||
Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency. | Q46685754 | ||
The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult | Q48452732 | ||
Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults | Q50957526 | ||
P433 | issue | 4 | |
P304 | page(s) | 259-264 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Neuroendocrinology | Q2410309 |
P1476 | title | Influence of body mass index on growth hormone responses to classic provocative tests in children with short stature | |
P478 | volume | 93 |
Q98779262 | Association between Insulin-Like Growth Factor-1 and Relative Skeletal Maturation: A Retrospective Cohort Study of Short Children and Adolescents |
Q28076439 | Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India |
Q35758276 | Diagnosis of growth hormone deficiency in childhood |
Q35529261 | Growth hormone responses to provocative tests in children with short stature |
Q91173821 | Impact of BMI on peak growth hormone responses to provocative tests and therapeutic outcome in children with growth hormone deficiency |
Q37147355 | Influence of body mass index on the growth hormone response to provocative testing in short children without growth hormone deficiency. |
Q40898636 | Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA). |
Search more.